Search hospitals > Texas > Dallas
Methodist Dallas Medical Center
Claim this profileDallas, Texas 75203
Global Leader in Wounds and Injuries
Conducts research for Liver Cirrhosis
Conducts research for Fibrosis
Conducts research for COVID-19
Conducts research for Coronavirus
135 reported clinical trials
6 medical researchers
Summary
Methodist Dallas Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of Wounds and Injuries, Liver Cirrhosis, Fibrosis, COVID-19, Coronavirus and other specialties. Methodist Dallas Medical Center is involved with conducting 135 clinical trials across 233 conditions. There are 6 research doctors associated with this hospital, such as Parvez Mantry, MD, Prashant Kedia, MD, Jose A. Castillo-Lugo, MD, and Bryce Bushe, MD.Top PIs
Parvez Mantry, MDThe Liver Institute at Methodist Dallas Medical Center3 years of reported clinical research
Studies Fatty Liver Disease
Studies Non-alcoholic Fatty Liver Disease
19 reported clinical trials
26 drugs studied
Prashant Kedia, MDMethodist Dallas Medical Center1 year of reported clinical research
Studies Bleeding
Studies Diverticulosis Bleeding
5 reported clinical trials
5 drugs studied
Jose A. Castillo-Lugo, MDMethodist Health System Clinical Research Institute6 years of reported clinical research
Studies HIV (Human Immunodeficiency Virus)
Studies Death
2 reported clinical trials
2 drugs studied
Bryce Bushe, MDMethodist Dallas Medical Center1 year of reported clinical research
Studies Bleeding
Studies Diverticulosis Bleeding
1 reported clinical trial
1 drug studied
Clinical Trials running at Methodist Dallas Medical Center
Acute Kidney Injury
Diverticulosis Bleeding
Pancreatitis
Pancreas Divisum
Continuous Renal Replacement Therapy
Regional Citrate Anticoagulation
Crisis Intervention Cart
Bleeding
Liver Disease
Coronary Heart Disease
Prismocitrate 18
for Acute Kidney Injury
Prismocitrate 18 is a continuous renal replacement therapy (CRRT) solution to be used as a renal replacement solution and as an anticoagulant to prevent blood clotting in the extracorporeal circuit. The objectives of this study are: 1) to confirm the safety of Prismocitrate 18 in patients receiving CRRT using continuous venovenous hemodiafiltration (CVVHDF) or continuous venovenous hemofiltration (CVVH) and 2) to observe that the PrisMax System allows for implementation of regional citrate anticoagulation (RCA) (citrate and calcium dosing) during CRRT with Prismocitrate 18 and intended prescription. The study period of the patient's CRRT will be up to 10 days.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Methodist Dallas Medical Center?
Methodist Dallas Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of Wounds and Injuries, Liver Cirrhosis, Fibrosis, COVID-19, Coronavirus and other specialties. Methodist Dallas Medical Center is involved with conducting 135 clinical trials across 233 conditions. There are 6 research doctors associated with this hospital, such as Parvez Mantry, MD, Prashant Kedia, MD, Jose A. Castillo-Lugo, MD, and Bryce Bushe, MD.